[NEJM] A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

 关闭 求助已关闭
kikibom 发表于 2026-7-21 13:10:55 | 显示全部楼层 |阅读模式
悬赏10积分

期刊:New England Journal of Medicine

文献作者:Stephen A. Harrison; Pierre Bedossa; Cynthia D. Guy; Jorn M. Schattenberg; Rohit Loomba; Rebecca Taub; Dominic Labriola; Sam E. Moussa; Guy W. Neff; Mary E. Rinella; Quentin M. Anstee; Manal F. Abdelmalek; Zobair Younossi; Seth J. Baum; Sven Francque; Michael R. Charlton; Philip N. Newsome; Nicolas Lanthier; Ingolf Schiefke; Alessandra Mangia; Juan M. Pericàs; Rashmee Patil; Arun J. Sanyal; Mazen Noureddin; Meena B. Bansal; Naim Alkhouri; Laurent Castera; Madhavi Rudraraju; Vlad Ratziu

出版日期:2024-2-8

DOI号:10.1056/nejmoa2309000

下载链接:http://www.nejm.org/doi/pdf/10.1056/NEJMoa2309000

文献链接:https://doi.org/10.1056/nejmoa2309000

当前文献来源于 Massachusetts Medical Society


备注信息:
全部回复0 显示全部楼层

发表回复

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

返回列表